In term of DSS, METTL1 activity deemed to be a hazard factor in ACC, KICH, KIRC, KIRP, LGG, LIHC, LUAD, MESO, as well as SKCM (Figure S4). Here, METTL1 is linked to adrenal cortex carcinoma.